Age-, Sex-, Race-Specific Standards for Thyroid Diseases May Reclassify Many Patients
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 14, 2025 -- Age-, sex-, and race-specific reference intervals for thyroid diseases reclassify many participants with subclinical hypothyroidism or hyperthyroidism as normal, according to a study published online May 6 in the Annals of Internal Medicine.
Qihang Li, M.D., from Shandong University in Jinan, China, and colleagues identified age-, sex-, and race-specific reference intervals for the common diagnostic tests that measure thyroid function and examined how these new reference intervals reclassify persons compared to current reference intervals in a cross-sectional study. Data were included from 8,308 U.S. National Health and Nutrition Examination Survey (NHANES) participants aged 20 years or older supplemented with 314,302 patients aged 18 years or older from a Chinese database from 49 hospitals in 10 provinces.
The researchers found that the 97.5th percentile levels of thyroid-stimulating hormone (TSH) increased with age in the NHANES participants, while total triiodothyronine levels decreased with age and total thyroxine (TT4) levels were stable across age. Higher TT4 levels were seen for women, and higher TSH levels were seen for White participants. The prevalence of subclinical hypothyroidism increased from 2.4 percent for ages 20 to 29 years to 5.9 percent for ages 70 years and older using current reference intervals. Using age-, sex-, and race-specific reference intervals, 48.5 percent of persons with subclinical hypothyroidism were reclassified as normal, especially women and White participants, and 31.2 percent of persons with subclinical hyperthyroidism were reclassified as normal, especially women, Black participants, and Hispanic participants.
"We expect that our findings will help decision makers establish more accurate reference intervals for thyroid diseases," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar Disorder
WEDNESDAY, Feb. 12, 2025 -- Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD)...
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
MONDAY, Nov. 25, 2024 -- Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at...
Potential Genetic Link ID'd Between Thyroid Disease, Alopecia Areata
WEDNESDAY, Oct. 30, 2024 -- There seems to be a significant association between hypothyroidism, Hashimoto thyroiditis, subacute thyroiditis, and alopecia areata (AA), according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.